17.10.2024
Researchers from the University of Texas at Dallas have discovered that gold nanoparticles may offer a more accurate method of detecting kidney disease than traditional blood tests. Their study suggests that X-ray imaging using gold nanoparticles as a contrast agent could improve kidney function assessment and provide crucial insights into nanoparticle-based therapies.21.05.2024
NYU Langone Health has achieved a medical milestone with the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery.23.04.2024
Researchers at the University Hospital Bonn, in collaboration with the University of Bonn, have developed a computer method to determine whether protein excretion in urine is caused by a few severely damaged or many slightly damaged kidney filters. The innovative findings were published in the journal Kidney International.18.12.2023
For the first time ever, wireless millirobots navigated a narrow blood vessel both along and against arterial flow. Researchers from the University of Twente and Radboudumc inserted the screw-shaped robots in a detached aorta with kidneys where they controlled them using a robotically controlled rotating magnet.08.12.2023
3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionise monitoring of kidney disease, which often progresses without symptoms in the early stages.24.10.2023
A new study conducted at the University of Leipzig Medical Center and supported by the Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG) shows that obesity affects the quality of ultrasound scans of the liver and kidneys.20.07.2023
Artificial intelligence is becoming increasingly important in drug discovery. Advances in the use of Big Data, learning algorithms and powerful computers have now enabled researchers at the University of Zurich (UZH) to better understand a serious metabolic disease.19.07.2023
Many hospitals use the adsorber CytoSorb to purify the blood of seriously ill patients in order to trap inflammatory substances and prevent the life-threatening cytokine storm. MHH researchers have now found in a meta-study that the treatment does not reduce mortality and may even cause harm.29.06.2023
The study demonstrates a significant improvement in predicting the response to therapy in metastatic renal cell carcinoma by incorporating the level of inflammation, which was assessed using two straightforward blood parameters, alongside the conventional imaging-based approach.12.05.2023
Magnetic Resonance Imaging (MRI) has shown a high potential to distinguish biomarkers for CKD, but renal MRI biomarkers are currently underused in research and clinical practice.03.01.2022
The shortage of donor organs is a major global issue. An aging population, a reluctance towards organ donation, and logistical challenges related to organ shipping play an important role in this setting. Machine perfusion can be a way to expand and preserve the donor pool for eligible transplant recipients.03.01.2022
Patients waiting for a donor organ must have a lot of patience and a bit of luck. Aging and a rise in chronic disease prevalence means the need for donor organs is much greater than the number that is available. To help those who need organ transplants, scientists must create new technologies.13.07.2021
Kidney stones are a widespread disease. In order to be able to reliably remove even the smallest remnants of them, Purenum GmbH, a spin-off of Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM, developed a gel that encloses small fragments and can then be removed without leaving any residue. This year, the product mediNiK was certified and is thus ready for the market.28.06.2021
In December 2017, Purenum GmbH started its business as a spin-off of Fraunhofer IFAM. Its mission is to develop biomimetic adhesives for use in medical technology.15.05.2019
New active substances that are suitable for drugs are initially tested in animal experiments. However, the results cannot always be transferred to the human organism. At the Karlsruhe Institute of Technology, Prof. Ute Schepers from vasQlab explains how active substances can be tested in human tissue without endangering human health.